Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Copper amino acid chelate complex - RR MedSciences

Next Previous
X
Search
Drug Profile

Copper amino acid chelate complex - RR MedSciences

Alternative Names: Copper amino acid chelate complex; Copper-XHA spray; RM 191A; RRM-CIP-01

Latest Information Update: 07 Apr 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator RR MedSciences
  • Class Analgesics; Neuropeptides; Organometallic compounds; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Neuropathic pain

Most Recent Events

  • 07 Apr 2021 Copper amino acid chelate complex is still in phase II trial for Neuropathic Pain in Australia (Topical, Spray) (ACTRN12617000206325) (RR MedSciences pipeline, April 2021)
  • 20 Jun 2017 RR MedSciences plans a pilot phase II trial for Neuropathic Pain in Australia (Topical, Spray) (ACTRN12617000206325)
  • 06 Feb 2017 Preclinical trials in Neuropathic pain in Australia (Topical) before February 2017

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top